title: Trials and Tribulations on the Path to Developing a Dengue Vaccine.
abstract: Dengue is a rapidly expanding global health problem. Development of a safe and efficacious tetravalent vaccine along with strategic application of vector control activities represents a promising approach to reducing the global disease burden. Although many vaccine development challenges exist, numerous candidates are in clinical development and one has been tested in three clinical endpoint studies. The results of these studies have raised numerous questions about how we measure vaccine immunogenicity and how these readouts are associated with clinical outcomes in vaccine recipients who experience natural infection. In this review the authors discuss the dengue vaccine pipeline, development challenges, the dengue vaccine-immunologic profiling intersection, and research gaps.
authors.affiliation: Walter Reed Army Institute of Research, Silver Spring, MD, USA. Electronic address: stephen.j.thomas3.mil@mail.mil.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Thomas
authors.affiliation: University of Rhode Island, Providence, RI, USA.
authors.forename: Alan L
authors.initials: AL
authors.lastname: Rothman
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D002986:Clinical Trials as Topic; D003715:Dengue / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D012107:Research Design; D014944:World Health Organization
chemical_list: D057134:Antibodies, Neutralizing; D053059:Dengue Vaccines